The firm served as lead counsel on behalf of Oklahoma Medical Research Foundation in a patent infringement suit brought in the Northern District of Oklahoma against Alexion Pharmaceuticals. The patents related to complement-inhibition technology and their use in a drug marketed by Alexion to treat a rare, debilitating and life-threatening disease. After replacing OMRF’s previous counsel in the matter and soon after claim construction briefing was complete, we obtained a settlement. It included payment to our client as well as public acknowledgement that individuals affiliated with OMRF were the true inventors of the technology at issue.

Oklahoma Med. Research Found. v. Alexion Pharmaceuticals, Inc., No. 07-163 (N.D. Okla. filed Mar. 15, 2007).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Employment litigation for a Fortune 500 retail company
Represented a Fortune 500 retail company in a former employee's discrimination lawsuit, which alleged hostile work environment, retaliation, more
Settlement of a major title insurance claim for a 54 acre development project
Served as lead counsel representing the developer of a high profile, 54 acre project in a major title insurance claim arising out of an easement more
Trademark and unfair competition matters for WMS Gaming Inc.
Represents WMS Gaming Inc., a leader in the video gaming equipment industry, in trademark litigation before federal trial and appellate courts more
Food safety disclosure requirements in connection with initial public offering of major doughnut manufacturer
Counseled major doughnut manufacturer on food safety disclosure requirements in connection with initial public offering. more